SGLT2 Inhibitor Diabetes Drugs May Cause Ketoacidosis: FDASGLT2 Inhibitor Diabetes Drugs May Cause Ketoacidosis: FDA

Reports of ketoacidosis requiring hospitalization in patients with type 2 diabetes taking sodium-glucose cotransporter-2 inhibitors prompts FDA drug safety communication. News Alerts
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news